SCHEMBL14896743

SCHEMBL14896743

Cc1cc([N+](=O)[O-])cc(Br)[n+]1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.45
HTT P42858 4/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
LMNA P02545 1/20 0.41
ALDH1A1 P00352 6/20 0.41
GPR35 Q9HC97 2/20 0.41
CYP3A4 P08684 4/20 0.39
TDP1 Q9NUW8 3/20 0.39
CYP19A1 P11511 1/20 0.39
ESPL1 Q14674 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GALR3 O60755 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ACHE P22303 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP1A2 P05177 2/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TTR P02766 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15452634 0.86 CYP19A1 (0.46) TSHRHTTKMT2AMEN1LMNA
SCHEMBL942208 0.79 TSHR (0.47) TSHRHTTKMT2AMEN1LMNA
SCHEMBL19975766 0.77 HTT (0.43) TSHRHTTKMT2AMEN1LMNA
SCHEMBL782341 0.71 CYP19A1 (0.48) TSHRHTTKMT2AMEN1LMNA
SCHEMBL589656 0.71 TSHR (0.56) TSHRHTTKMT2AMEN1LMNA
SCHEMBL15354544 0.69 TSHR (0.48) TSHRHTTKMT2AMEN1LMNA
SCHEMBL28900485 0.68 CYP19A1 (0.62) TSHRHTTKMT2AMEN1LMNA
SCHEMBL2659395 0.67 ALDH1A1 (0.57) TSHRHTTKMT2AMEN1LMNA
SCHEMBL1362507 0.67 TSHR (0.56) TSHRHTTKMT2AMEN1LMNA
SCHEMBL11613442 0.66 TSHR (0.44) TSHRHTTKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013059587-A1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2013-04-25 WO disclosed